SD
Subhadra Dravida
About Subhadra Dravida
Data last updated:
Subhadra Dravida is a Director at Transcell Biosciences Private Limited (since 2022) and Managing Director at Tran-Scell Biologics Private Limited (since 2009). The companies operate in Chemicals, Healthcare and Research & Development. The 2 current companies with reported revenue have a combined latest revenue of ₹7.01 Cr; the largest is Transcell Biosciences Private Limited at ₹5.58 Cr (FY 2025). Earlier, Subhadra Dravida was a Director at Transtox Bioapplications Private Limited (2014–2019) and Director at Transcell Oncologics Private Limited (from 2017) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Transcell Biosciences Private Limited U24290TG2022PTC162503 | Director | 11 May 2022 | 2022 | ₹5.58 Cr (FY 2025) | Active |
| Tran-Scell Biologics Private Limited U85100TG2009PTC066172 | Managing Director | 07 Dec 2009 | 2009 | ₹1.44 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Transtox Bioapplications Private Limited U73100TG2013PTC091742 | Director | 01 Feb 2014 | 2013 | Active | |
 Transcell Oncologics Private Limited U74999TG2017PTC118680 | Director | 02 Aug 2017 | 2017 | ₹4.04 Cr (FY 2023) | Amalgamated |
| Transcell Biolife Private Limited U74999TG2017PTC118697 | Director | 03 Aug 2017 | 2017 | ₹2.88 Cr (FY 2023) | Amalgamated |
| Elvira Life Sciences Private Limited U85190TG2009PTC064337 | Director | 19 Oct 2009 | 2009 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Subhadra Dravida
| Name | DIN | Company | Designation |
|---|---|---|---|
| Uday Chatterjee | 00492413 | Transcell Biosciences Private Limited , Tran-Scell Biologics Private Limited | Director |
| Asif Wahidul Hasan | 06612304 | Tran-Scell Biologics Private Limited | Director |
| Vinayender Tulla | 01041344 | Tran-Scell Biologics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Subhadra Dravida
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Subhadra Dravida
Subhadra Dravida currently holds 2 directorships: Transcell Biosciences Private Limited (Director, since 11 May 2022, revenue ₹5.58 Cr (FY 2025)); Tran-Scell Biologics Private Limited (Managing Director, since 07 Dec 2009, revenue ₹1.44 Cr (FY 2025)).
Subhadra Dravida was first appointed on 19 Oct 2009 as Director at Elvira Life Sciences Private Limited. The most recent appointment on record is 11 May 2022 at Transcell Biosciences Private Limited.
The 2 current companies of Subhadra Dravida that report revenue have a combined latest revenue of ₹7.01 Cr: Transcell Biosciences Private Limited ₹5.58 Cr (FY 2025); Tran-Scell Biologics Private Limited ₹1.44 Cr (FY 2025).
Subhadra Dravida held 4 earlier board appointments: Transtox Bioapplications Private Limited (Director, 01 Feb 2014 to 01 Jun 2019); Transcell Oncologics Private Limited (Director, from 02 Aug 2017); Transcell Biolife Private Limited (Director, from 03 Aug 2017); Elvira Life Sciences Private Limited (Director, from 19 Oct 2009).
The current boards of Subhadra Dravida's companies include Uday Chatterjee (Transcell Biosciences Private Limited), Asif Wahidul Hasan (Tran-Scell Biologics Private Limited), Vinayender Tulla (Tran-Scell Biologics Private Limited).